Summary & Overview
HCPCS L8687: Implantable Rechargeable Neurostimulator Pulse Generator, Dual Array
HCPCS Level II code L8687 represents an implantable, rechargeable neurostimulator pulse generator configured for dual-array leads and supplied with an extension. Implantable neurostimulators are used in neuromodulation therapies for chronic pain, movement disorders, and other refractory neurologic conditions; a specific device-level code such as L8687 matters nationally because it affects billing, device tracking, and payment across hospital and ambulatory surgical settings. Key payers in the national landscape include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. This publication provides clinicians, billing professionals, and policy analysts with benchmarks and context for L8687, including the clinical service type (implantable neurostimulation device provision/implantation), typical sites of service (inpatient hospitals and outpatient surgical centers), and payer coverage considerations. Readers will learn the basic device description and clinical setting, common procedural contexts where the device is billed, and where to find related coding and policy references. Data not available in the input for specific payer reimbursement rates, associated taxonomies, ICD-10 diagnosis mappings, and related codes are noted where relevant.
Billing Code Overview
HCPCS Level II code L8687 describes an implantable neurostimulator pulse generator, dual array, rechargeable, includes extension. This device is a rechargeable implantable pulse generator designed to support dual-array neurostimulation leads and includes the extension component as part of the device package.
Service type: Implantable neurostimulation device implantation / device provision
Typical site of service: Inpatient hospital or outpatient surgical center
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with chronic, refractory neuropathic pain (for example, failed back surgery syndrome or complex regional pain syndrome) who has not achieved adequate relief from conservative treatments including medications, physical therapy, and interventional procedures. After multidisciplinary evaluation and a successful trial of an implanted neurostimulator system, the patient is scheduled for placement of a permanent implantable neurostimulator pulse generator, dual array, rechargeable, which includes the extension lead(s). The procedure is typically performed in an operating room or an ambulatory surgery center under monitored anesthesia care or general anesthesia. The clinical workflow includes preoperative device and wound site planning, intraoperative fluoroscopic guidance for lead positioning, connection of extension leads to the dual-array rechargeable pulse generator, intraoperative neurostimulator system testing and programming, wound closure, and postoperative device recharge and patient education on charging and use. Typical follow-up includes wound checks, device programming adjustments in clinic, and routine rechargeable maintenance education.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Standard reporting when no specific modifier applies |
22 |